Document is current
Any future updates will be listed below
-
Authors
Chatterjee, Madhurima
Özdemir, Selcuk
Fritz, Christian
Möbius, Wiebke https://orcid.org/0000-0002-2902-7165
Kleineidam, Luca
Mandelkow, Eckhard https://orcid.org/0000-0003-4655-4829
Biernat, Jacek
Doğdu, Cem
Peters, Oliver
Cosma, Nicoleta Carmen https://orcid.org/0000-0002-2656-8046
Wang, Xiao
Schneider, Luisa-Sophia
Priller, Josef https://orcid.org/0000-0001-7596-0979
Spruth, Eike
Kühn, Andrea A. https://orcid.org/0000-0002-4134-9060
Krause, Patricia
Klockgether, Thomas
Vogt, Ina R.
Kimmich, Okka
Spottke, Annika
Hoffmann, Daniel C.
Fliessbach, Klaus
Miklitz, Carolin
McCormick, Cornelia
Weydt, Patrick
Falkenburger, Björn
Brandt, Moritz
Guenther, René
Dinter, Elisabeth
Wiltfang, Jens
Hansen, Niels
Bähr, Mathias
Zerr, Inga
Flöel, Agnes
Nestor, Peter J.
Düzel, Emrah
Glanz, Wenzel
Incesoy, Enise
Bürger, Katharina
Janowitz, Daniel
Perneczky, Robert
Rauchmann, Boris S.
Hopfner, Franziska
Wagemann, Olivia
Levin, Johannes
Teipel, Stefan
Kilimann, Ingo
Goerss, Doreen
Prudlo, Johannes
Gasser, Thomas
Brockmann, Kathrin https://orcid.org/0000-0002-7515-8596
Mengel, David
Zimmermann, Milan
Synofzik, Matthis
Wilke, Carlo
Selma-González, Judit
Turon-Sans, Janina
Santos-Santos, Miguel Angel
Alcolea, Daniel https://orcid.org/0000-0002-3819-3245
Rubio-Guerra, Sara https://orcid.org/0000-0001-7652-8029
Fortea, Juan https://orcid.org/0000-0002-1340-638X
Carbayo, Álvaro https://orcid.org/0000-0001-9282-8603
Lleó, Alberto https://orcid.org/0000-0002-2568-5478
Rojas-García, Ricardo
Illán-Gala, Ignacio
Wagner, Michael
Frommann, Ingo https://orcid.org/0000-0002-7244-2014
Roeske, Sandra https://orcid.org/0000-0002-8262-4356
Bertram, Lucas https://orcid.org/0009-0005-3594-6925
Heneka, Michael T. https://orcid.org/0000-0003-4996-1630
Brosseron, Frederic
Ramirez, Alfredo https://orcid.org/0000-0003-4991-763X
Schmid, Matthias
Beschorner, Rudi https://orcid.org/0000-0003-1109-915X
Halle, Annett
Herms, Jochen
Neumann, Manuela
Barthélemy, Nicolas R.
Bateman, Randall J. https://orcid.org/0000-0002-7729-1702
Rizzu, Patrizia
Heutink, Peter
Dols-Icardo, Oriol https://orcid.org/0000-0003-2656-8748
Höglinger, Günter https://orcid.org/0000-0001-7587-6187
Hermann, Andreas https://orcid.org/0000-0002-7364-7791
Schneider, Anja https://orcid.org/0000-0001-9540-8700
- License Information
-
More Information
Article History
Received: 10 July 2023
Accepted: 21 March 2024
First Online: 18 June 2024
Competing interests
: All authors had access to the data in the study and accepted responsibility for submitting the paper for publication. A. Schneider serves in a scientific advisory board for and receives honoraria from Biogen. She additionally received funding for a scientific collaboration from Eisai and honoraria for presentations from Eisai. M.C. is currently an employee of uniQure Biopharma B.V. and recipient of employee stock options. F.H. receives author fees from Thieme medical publishers and W. Kohlhammer GmbH medical publishers. P.H. is an employee and owns stock in Alector LLC. K. Brockmann is a consultant for F. Hoffmann-La Roche Ltd, Vanqua Bio and the Michael J. Fox Foundation for Parkinson’s Research and has received speaker honoraria from AbbVie, Lundbeck, UCB (Union Chimique Belge) and Zambon. N.H. has received travel support from Eli Lilly. A. Hermann has received honoraria for presentations and participation in advisory boards from Amylyx and IFT Pharma. He has received royalities from Elsevier Press and Kohlhammer. Washington University and R.J.B. have equity ownership interest in C2N Diagnostics and R.J.B. receives income from C2N Diagnostics for serving on the scientific advisory board. R.J.B. and N.R.B. may receive income based on technology (methods to detect microtubule binding region (MTBR) tau isoforms and use thereof) licensed by Washington University to C2N Diagnostics. R.J.B. has received research funding from Avid Radiopharmaceuticals, Janssen, Roche/Genentech, Eli Lilly, Eisai, Biogen, AbbVie, Bristol Myers Squibb and Novartis. R.J.B. serves on the Roche Gantenerumab Steering Committee as an unpaid member. R.G. received speaker fees and nonfinancial support from Biogen, Roche, Zambon and research support from Biogen, ITF Pharma and Zambon outside this work. D.A. participated in advisory boards from Fujirebio-Europe, Roche Diagnostics, Grifols S.A. and Lilly, and received speaker honoraria from Fujirebio-Europe, Roche Diagnostics, Nutricia, Krka Farmacéutica S.L., Zambon S.A.U. and Esteve Pharmaceuticals S.A. D.A. declares a filed patent application (WO2019175379 A1 Markers of synaptopathy in neurodegenerative disease). J.W. received lecture honoraria from Beeijing Yibai Science and Technology Ltd, Gloryren, Janssen Cilag, Pfizer, Med Update GmbH, Roche Pharma, Lilly and serves on advisory boards for Biogen, Abbott, Boehringer Ingelheim, Lilly, MSD Sharp & Dohme and Roche. M. Brandt received speaker honoraria from Idorsia, Eisai and Bristol Myers Squibb. All other authors state no competing interests.
